基于体素的序贯放疗计划评估:不同剂量分割方案
本研究提出一种基于体素的方法,用于评估两阶段序贯放疗计划(第一阶段常规分割、第二阶段大分割),并以前列腺癌病例演示。利用Varian Eclipse计划系统勾画和设计,第一阶段PTV 52 Gy/26次,第二阶段PTV Boost 19.5 Gy/3次,通过VRb工具重建BED-Cube和EQD2-Cube并计算TCP和NTCP。结果显示联合靶区TCP为90.56%,膀胱和直肠NTCP分别为0.33%和约0.0%,作者认为该方法优于现有方法。
要点
- 基于体素的VRb工具可对多阶段不同分割方案的放疗计划进行生物学评估。
- 前列腺癌病例中联合靶区TCP为90.56%,膀胱NTCP为0.33%,直肠NTCP约0.0%。
- 按PTV、CTV和OAR优先级显示模式有助于理解序贯放疗计划的放射生物学评估。
核心结论
- 作者认为,使用VRb工具的所提方法对多阶段序贯放疗计划的评估优于现有方法。
研究设计与样本
- 本研究为方法学展示,选取一例前列腺癌病例进行演示。
- 使用Varian Eclipse治疗计划系统进行勾画和计划设计。
- 第一阶段PTV给予52 Gy/26次,第二阶段PTV Boost给予19.5 Gy/3次,均基于同一CT数据集。
- 两个计划导出后使用「基于体素的放射生物学显示(VRb)工具」处理,结合线性二次(LQ)和线性二次-线性(LQ-L)放射生物学模型重建BED-Cube和EQD2-Cube的Plan Sum。
诊断标准与关键数值
- 联合靶区的基于体素TCP为90.56%。
- 膀胱NTCP为0.33%,直肠NTCP约为0.0%,由Plan Sum直方图计算得出。
临床应用与阅片要点
- 作者认为,VRb工具中基于PTV、CTV和OAR优先级的显示模式有助于更好地理解序贯放疗计划的放射生物学评估。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: This study presents a methodology for voxel-based evaluation of two phase sequential radiotherapy treatment plans having conventional dose scheme in the first phase and subsequent hypofractionation dose scheme in the second phase based upon different priority [planning target volume (PTV), clinical target volume (CTV) and organs at risk (OAR)] of display modes.
METHODS: A case of carcinoma prostate was selected for demonstration. Varian Eclipse treatment planning system (TPS) was used for contouring and planning. In the first phase, a dose of 52 Gy in 26 fractions to the PTV and in the second phase, a dose of 19.5 Gy in 3 fractions to the PTV Boost was planned on the same CT data set. Both the plans (Phase 1 and Phase 2) were exported and processed using "Voxel-based radiobiology display (VRb) tool". Plan Sum for Biologically effective dose (BED)-Cube and equivalent dose of 2Gy (EQD2)-Cube was reconstructed using a combination of linear quadratic (LQ) and linear quadratic-linear (LQ-L) radiobiological models. Tumor control probability (TCP) and normal tissue complication probability (NTCP) for different target volumes and organs were also calculated using EQD2-volume histograms of the Plan Sum.
RESULTS: An in-house graphical user interface (GUI) is developed to present the qualitative and quantitative evaluation of the multiphase treatment plans with different display modes and dose regimens. The voxel based TCP obtained for the combined target volume was 90.56%. NTCP for the bladder and rectum was calculated from the Plan Sum histograms and found to be 0.33% and ~0.0% respectively.
CONCLUSION: The proposed methodology using the VRb tool offers superior plan evaluation for multiphase sequential radiotherapy treatment plans over the existing methods.
ADVANCES IN KNOWLEDGE: PTV, CTV and OAR priority based display modes in VRb tool offers better understanding of radiobiological evaluation of sequential radiotherapy treatment plans.
引用
- Singh G, Kamal R, Thaper D, et al. Voxel based evaluation of sequential radiotherapy treatment plans with different dose fractionation schemes. Br J Radiol. 2020. PMID: 32614607. doi:10.1259/bjr.20200197
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。